Europe — EMA
Olanzapina Accord (Olanzapine)
Olanzapine, the active ingredient in Olanzapina Accord, is an atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapina Accord, is an atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapina Accord is an atypical antipsychotic that works by modulating the dopamine and serotonin pathways in psychiatric disorders.
- Schizophrenia: Improves psychotic symptoms such as delusions and hallucinations. - Bipolar I disorder: Helps stabilise mood and reduce manic episodes. - Bipolar depressive phase of bipolar disorder : -
